Latest 8-K filings

NASDAQ
Aethlon Medical, Inc. announced a 1-for-5 reverse stock split to manage dilution and maintain Nasdaq compliance, effective July 31, 2026.
NASDAQ
Oxford Square Capital Corp. announced its second quarter 2026 financial results, reporting a net asset value of $1.29 per share and declaring distributions for October, November, and December 2026.
NASDAQ
Lulus Fashion Lounge Holdings, Inc. has entered into a Second Amendment to its Loan and Security Agreement, enhancing its ability to borrow against inventory and adjusting reporting requirements.
NYSE
WisdomTree, Inc. announced record Assets Under Management (AUM) of $162.9 billion for Q2 2026, alongside a 13% annualized organic flow growth rate and significant operating margin expansion.
NASDAQ
Moleculin Biotech announces updated preliminary blinded results from its Phase 2/3 MIRACLE trial for Annamycin in R/R AML, showing promising remission rates, especially in patients who failed prior venetoclax therapy.
AMEX
Imperial Oil Limited announced its third quarter 2026 dividend of 87 cents per share, maintaining the same rate as the previous quarter.
NYSE
Colgate-Palmolive reported a 4.9% increase in net sales and a 2.4% rise in organic sales for Q2 2026, but GAAP EPS decreased by 5% while Base Business EPS grew 8%.
NYSE
AbbVie Inc. announced robust second-quarter 2026 financial results, with net revenues up 10.2% and adjusted diluted EPS increasing 22.9%, alongside a definitive agreement to acquire Apogee Therapeutics for approximately $10.9 billion.
NASDAQ
IES Holdings Inc. announced robust third-quarter fiscal 2026 financial results, including a 40% revenue increase and a 60% operating income jump, alongside a two-for-one stock split.
NASDAQ
Seer, Inc. confirms receipt of two revised, unsolicited acquisition proposals, one from the Radoff-JEC Group for $2.55 per share and another from CEO Omid Farokhzad for $2.45 per share plus contingent value rights.
NASDAQ
Perella Weinberg Partners announced second quarter 2026 financial results, with revenues up 1% year-over-year, while first-half revenues declined 17%.
NYSE
CubeSmart announced its second quarter 2026 financial results, highlighting steady revenue growth and the formation of a new joint venture with Heitman.
NYSE
Gates Industrial Corporation Ltd. announced robust second-quarter 2026 financial results, exceeding expectations with record sales and earnings per share, leading to an upward revision of full-year guidance.
NYSE
Perimeter Solutions announced its second quarter 2026 financial results, showing a 31% increase in net sales to $213.8 million, driven by acquisitions and strong performance in its Specialty Products segment, alongside the acquisition of Monaco Enterprises.
NASDAQ
Dragonfly Energy Holdings Corp. has completed the strategic acquisition of substantially all operating assets of the Dakota Lithium brand for $4 million, expanding its market reach and expecting Adjusted EBITDA accretion.
NYSE
Federal Realty Investment Trust reported strong Q2 2026 results, highlighted by record leasing activity and a raised 2026 guidance, demonstrating robust operational performance.
NASDAQ
Balchem Corporation announced record net sales, net earnings, and adjusted EBITDA for the second quarter of 2026, driven by strong performance across all three reporting segments.
NYSE
Dominion Energy announced second-quarter 2026 results, with operating earnings per share of $0.79, and reaffirmed its full-year 2026 operating earnings guidance.
BTS
Cboe Global Markets announced record net revenue of $731.6 million and a 50% increase in diluted EPS for the second quarter of 2026.
NASDAQ
Linde plc announced robust second-quarter 2026 financial results, showcasing record sales and earnings growth, alongside a strengthened project backlog.
NASDAQ
Inovio Pharmaceuticals announced the pricing of a public offering of common stock and warrants, expecting to raise approximately $20.0 million.
NASDAQ
Tenax Therapeutics announced its second quarter 2026 financial results, highlighting a strong cash position and providing an update on its pivotal Phase 3 LEVEL clinical trial, with topline data anticipated in August 2026.
OTC.Pink
TXNM Energy announced second quarter 2026 results, with GAAP diluted EPS of $0.64 and ongoing diluted EPS of $0.58, while extending its acquisition agreement with Blackstone Infrastructure to May 31, 2027.
NYSE
TXNM Energy announced second quarter 2026 results, with GAAP diluted EPS of $0.64 and ongoing diluted EPS of $0.58, while extending its acquisition agreement with Blackstone Infrastructure to May 31, 2027.
NASDAQ
Newell Brands reported a significant return to year-over-year growth in net and core sales for the second quarter of 2026, exceeding expectations and leading to an upward revision of its full-year outlook.
NASDAQ
Werewolf Therapeutics reported Q2 2026 financial results, including $21.0 million in collaboration revenue from an asset sale, and provided an update on its strategic alternatives process.
NYSE
Church & Dwight announced strong second-quarter results, surpassing its own outlook for sales and earnings, and consequently raised its full-year financial guidance.
NASDAQ
T. Rowe Price Group announced its second quarter 2026 financial results, highlighting record assets under management and a return of capital to stockholders.
NASDAQ
Moderna reported Q2 2026 results with flat revenue of $145 million, a GAAP net loss of $0.8 billion, and improved operating expense outlook for the year.
NYSE
Enbridge Inc. announced strong second quarter 2026 financial results, reaffirming its full-year guidance and showcasing a growing secured backlog of $41 billion.